Paul J. Mellett
2015
In 2015, Paul J. Mellett earned a total compensation of $1.5M as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $122,542 |
|---|---|
| Option Awards | $960,157 |
| Salary | $344,862 |
| Stock Awards | $86,158 |
| Other | $15,706 |
| Total | $1,529,425 |
Mellett received $960.2K in option awards, accounting for 63% of the total pay in 2015.
Mellett also received $122.5K in bonus, $344.9K in salary, $86.2K in stock awards and $15.7K in other compensation.
Rankings
In 2015, Paul J. Mellett's compensation ranked 5,885th out of 13,638 executives tracked by ExecPay. In other words, Mellett earned more than 56.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,885 out of 13,638 | 57th |
Division Manufacturing | 2,191 out of 5,190 | 58th |
Major group Chemicals And Allied Products | 791 out of 1,854 | 57th |
Industry group Drugs | 631 out of 1,528 | 59th |
Industry Pharmaceutical Preparations | 495 out of 1,182 | 58th |
Source: SEC filing on January 6, 2017.
Mellett's colleagues
We found two more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2015.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019